Trial
NCT00566111
Ceftriaxone in the Management of Bipolar Depression
UnknownTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Yale University
Collaborators
Stanley Medical Research Institute
Condition
Bipolar Depression
Intervention
ceftriaxone
Why stopped
Early indication of an unfavorable risk/benefit ratio.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-31